References
- Bustamante JM, Tarleton RL. Potential new clinical therapies for Chagas disease. Expert Rev Clin Pharmacol 2014;7(3):317-25
- Logan FJ, Taylor MC, Wilkinson SR, et al. The terminal step in vitamin C biosynthesis in Trypanosoma cruzi is mediated by a FMN-dependent galactonolactone oxidase. Biochem J 2007;407(3):419-26
- Monteiro G, Horta BB, Pimenta DC, et al. Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C. Proc Natl Acad Sci USA 2007;104(12):4886-91
- Marim RG, Gusmao AS, Castanho RE, et al. Effects of vitamin C supplementation on acute phase Chagas disease in experimentally infected mice with Trypanosoma cruzi QM1 strain. Rev Inst Med Trop Sao Paulo 2012;54(6):319-23
- Ciccarelli AB, Frank FM, Puente V, et al. Antiparasitic Effect of Vitamin B12 on Trypanosoma cruzi. Antimicrob Agents Chemother 2012;56(10):5315-20
- Solovieva ME, Soloviev VV, Akatov VS. Vitamin B12b increases the cytotoxicity of short-time exposure to ascorbic acid, inducing oxidative burst and iron-dependent DNA damage. Eur J Pharmacol 2007;566(1-3):206-14
- Ramirez LE, Lages-Silva E, Pianetti GM, et al. Prevention of transfusion-associated Chagas’ disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light. Transfusion 1995;35(3):226-30